- Home
- INSG vs IBIO Comparison
INSG vs IBIO Comparison
Compare INSG & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSG | IBIO |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.9M | 83.5M |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | INSG | IBIO |
|---|---|---|
| Price | $4.25 | $1.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $15.33 | $4.75 |
| AVG Volume (30 Days) | 191.7K | ★ 452.1K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.71 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $313,832,000.00 | N/A |
| Revenue This Year | $16.21 | N/A |
| Revenue Next Year | $13.28 | N/A |
| P/E Ratio | $32.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.93 | $0.78 |
| 52 Week High | $21.90 | $3.82 |
Technical Indicators
Market Signals| Indicator | INSG | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 37.70 | 39.94 |
| Support Level | $3.94 | $1.21 |
| Resistance Level | $4.61 | $1.52 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 41.29 | 39.39 |
Price Performance
Historical ComparisonAbout INSG Inseego Corp.
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.